U.S. health regulators have approved a new Johnson & Johnson drug for patients with Tuberculosis who do not respond to other treatments, the company said.
The drug is the first in 40 years to tackle the disease, Read More: http://beforeitsnews.com/alternative/2012/12/u-s-approves-drug-resistant-tuberculosis-treatment-from-jj-2525678.html
The drug is the first in 40 years to tackle the disease, Read More: http://beforeitsnews.com/alternative/2012/12/u-s-approves-drug-resistant-tuberculosis-treatment-from-jj-2525678.html
